Uncertainty & Complexity
Digital Dialogues and Human Silences: Can AI Ever Truly Practice Therapy?
The soul, said Emerson, "refuses all methods." And yet, medicine has never stopped trying to methodize the soul. Now, in...
Read more
Muted by the Algorithm: The Unseen Censorship of Women’s Health
A pad. A period. A hot flash. These everyday realities for half the global population remain shadowed in euphemism and...
Read more
A Fragile Victory: Why Falling U.S. Overdose Deaths Signal Progress—but Not Relief
A decline in death doesn’t mean the epidemic is over. But it might mean the country is finally listening. In...
Read moreThe New Face of Teen Nicotine Addiction: How Zyn and Nicotine Pouches Are Outpacing Public Health
They come in mint, citrus, and coffee. They promise calm, focus, and a social edge. And they’re showing up in...
Read more
The First CRISPR Baby Cure: A Custom Gene Therapy and the Future of Personalized Medicine
One child’s life may have just changed the future of medicine. In a story that reads like science fiction turned...
Read more
Algorithms at the Gate: The FDA’s Thirty-Day Sprint to a Generative-AI Future
The Clock Starts Now At 7:14 a.m. on May 8, Commissioner Martin A. Makary strode into the FDA media room...
Read more
Frontier of Contagion: How a Single Brazilian Outbreak Rewired the Global Poultry Map
The Surprise Nobody Wanted The telephone rang in Brasília at 3:38 a.m. on May 16. By dawn, agriculture-ministry officials had...
Read more
From Bedside to Brand: Personalized Healthcare Marketing and the Changing Face of Patient Engagement
A cardiologist dances to trending audio while explaining atrial fibrillation. A plastic surgeon answers breast implant questions through TikTok comments....
Read more
The Language of the Algorithm: How Medical Terminology Shapes Health Searches
You’re at home on a quiet Sunday evening, and something doesn’t feel right. Maybe you’re dizzy. Maybe your hair seems...
Read more
The Algorithm of Doubt: How Health Misinformation Flourishes on Social Media
It begins innocently. A wellness influencer with a soft aesthetic and 200,000 followers posts a reel about the dangers of...
Read more
Tracking or Trapped? The Clinical Line Between Health Data and Digital Noise
The modern stethoscope fits around the wrist. Sleek, charged, and GPS-enabled, wearable health devices like the Apple Watch, Fitbit, Oura...
Read more
The Grey Market of Weight Loss: How Compounded GLP-1 Medications Continue Despite FDA Crackdowns
It began as a solution to scarcity. When GLP-1 receptor agonists like Ozempic and Wegovy were first introduced, they quickly...
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more